Pharmaceutical Updates

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference that will be held on 8–9 October 2026 in Kolkata. The...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...

CDSCO Issues Final Guidance for Medical Device Software Under MDR 2017

The Central Drugs Standard Control Organisation (CDSCO), functioning under the Directorate General of Health Services, Ministry of Health...

Alembic’s New Gujarat Hub to Speed Up Medicine Supply

Alembic Pharmaceuticals Limited has marked a significant step forward in its logistics infrastructure with the launch of a new Central Stock Point (CSP) in Kheda,...

Union Health Minister Reviews Dengue Preparedness in Delhi

Union Health and Family Welfare Minister Shri J.P. Nadda convened a high-level meeting on July 1, 2026, to evaluate Delhi's readiness for the dengue season. Officials...

Gujarat Charts Course to Become India’s Leading Biotechnology Hub by 2030

A newly released study by the Gujarat Rajya Institute for Transformation (GRIT) has laid out a strategic vision for positioning Gujarat as India's foremost biotechnology and biomanufacturing centre...

Aurobindo Pharma USA Secures FTC Nod for Lannett Company Acquisition Deal

Aurobindo Pharma USA, Inc. (“Aurobindo USA”), a wholly owned subsidiary of the Aurobindo Pharma Limited, earlier in this week had announced that it has received approval from the U.S. Federal...

Mayo Clinic Finds Common Surgical Drug Could Reduce Risk of Liver Failure

Researchers at Mayo Clinic and Michigan State University have uncovered a potentially life-saving application for tranexamic acid, a widely used clot-preserving medication, in the context of...

Shilpa Biologicals Activates GMP-Certified ADC Manufacturing Hub in Dharwad, India

Shilpa Biologicals, the biologics arm of Raichur-based Shilpa Medicare Ltd., has formally activated its antibody–drug conjugate (ADC) drug substance manufacturing facility in Dharwad, India. The plant is currently...